首页> 外文期刊>Journal of proteomics >Application of targeted mass spectrometry in bottom-up proteomics for systems biology research
【24h】

Application of targeted mass spectrometry in bottom-up proteomics for systems biology research

机译:靶标质谱法在系统生物学研究中自下而上的蛋白质组学中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

The enormous diversity of proteoforms produces tremendous complexity within cellular proteomes, facilitates intricate networks of molecular interactions, and constitutes a formidable analytical challenge for biomedical researchers. Currently, quantitative whole-proteome profiling often relies on non-targeted liquid chromatography–mass spectrometry (LC-MS), which samples proteoforms broadly, but can suffer from lower accuracy, sensitivity, and reproducibility compared with targeted LC-MS. Recent advances in bottom-up proteomics using targeted LC-MS have enabled previously unachievable identification and quantification of target proteins and posttranslational modifications within complex samples. Consequently, targeted LC-MS is rapidly advancing biomedical research, especially systems biology research in diverse areas that include proteogenomics, interactomics, kinomics, and biological pathway modeling. With the recent development of targeted LC-MS assays for nearly the entire human proteome, targeted LC-MS is positioned to enable quantitative proteomic profiling of unprecedented quality and accessibility to support fundamental and clinical research. Here we review recent applications of bottom-up proteomics using targeted LC-MS for systems biology research. SignificanceAdvances in targeted proteomics are rapidly advancing systems biology research. Recent applications include systems-level investigations focused on posttranslational modifications (such as phosphoproteomics), protein conformation, protein-protein interaction, kinomics, proteogenomics, and metabolic and signaling pathways. Notably, absolute quantification of metabolic and signaling pathway proteins has enabled accurate pathway modeling and engineering. Integration of targeted proteomics with other technologies, such as RNA-seq, has facilitated diverse research such as the identification of hundreds of “missing” human proteins (genes and transcripts that appear to encode proteins but direct experimental evidence was lacking).
机译:巨型多样性的蛋白质om6在细胞蛋白质组中产生巨大的复杂性,促进分子相互作用的复杂网络,并构成生物医学研究人员的突出分析挑战。目前,定量的全蛋白质组分析通常依赖于非靶向液相色谱 - 质谱(LC-MS),其在广泛上样品,但与靶向LC-MS相比,可以患上较低的精度,灵敏度和再现性。使用靶标LC-MS的自下而上的蛋白质组学的最新进展使得先前在复杂样品中的目标蛋白质和靶蛋白的靶向和定量进行了识别和定量。因此,有针对性的LC-MS正在迅速推进生物医学研究,特别是在不同地区的系统生物学研究,包括蛋白质组织中的蛋白质组织,别术,护版和生物途径建模。随着靶向LC-MS测定的近期整个人类蛋白质组的最近,定位的LC-MS定位以使定量蛋白质组学分析能够提供前所未有的质量和可及性,以支持基本和临床研究。在这里,我们审查最近使用针对系统生物学研究的目标LC-MS的自下而上蛋白质组学的应用。靶向蛋白质组学中的重要性是迅速推进系统生物学研究。最近的应用包括焦点的系统水平调查,其专注于发生后期修饰(如磷蛋白质),蛋白质构象,蛋白质 - 蛋白质相互作用,护力学,蛋白质组织和代谢和信号传导途径。值得注意的是,代谢和信号通路蛋白的绝对量化使能够精确的途径建模和工程。靶向蛋白质组学与其他技术(如RNA-SEQ)的整合促进了多样化的研究,例如鉴定数百的“缺失”人蛋白(基因和转录似乎编码蛋白质但直接实验证据的基因和转录物缺乏)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号